Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong · Delayed Price · Currency is HKD 70.05
-5.40 (-7.16%)
At close: Jun 1, 2026
Vigonvita Life Sciences Market Cap
Vigonvita Life Sciences has a market cap or net worth of 11.74 billion as of June 1, 2026.
Market Cap
11.74B
Enterprise Value
11.87B
Revenue
113.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
70.05
Market Cap Chart
Since November 6, 2025, Vigonvita Life Sciences's market cap has decreased from 13.74B to 11.74B, a decrease of -14.57%. That is a compound annual growth rate of -24.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 11.74B | -14.42% |
| Dec 31, 2025 | 13.72B | -0.18% |
| Nov 6, 2025 | 13.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 250.87B |
| Hansoh Pharmaceutical Group Company | 190.62B |
| Innovent Biologics | 144.88B |
| WuXi Biologics | 138.06B |
| TransThera Sciences (Nanjing) | 14.29B |
| CStone Pharmaceuticals | 12.87B |
| Nanjing Leads Biolabs | 12.19B |
| Angelalign Technology | 12.02B |